Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate

/Home/Lyophilization and Protein Formulation Patents/Patent Articles - Lyophilization/Patent Pending - Lyophilization

United States Patent Application 20020182226
Kind Code A1
Peetermans, Julien ; et al. December 5, 2002
Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
Abstract
The invention relates to a vaccine formulation for the prevention of Haemophilus Influenzae Type B (Hib) infections and where the antigen is adsorbed onto aluminium phosphate. The invention also relates to a multivalent vaccines, that is a vaccine for the amelioration or treatment of more than one disease states. The present invention also relates to the production and use of such vaccines in medicine.
Inventors: Peetermans, Julien; (Rixensart, BE) ; Hauser, Pierre; (Chaumont-Gistoux, BE)
Correspondence Name and Address: SMITHKLINE BEECHAM CORPORATION
CORPORATE INTELLECTUAL PROPERTY-US, UW2220
P. O. BOX 1539
KING OF PRUSSIA
PA
19406-0939
US
Serial No.: 155052
Series Code: 10
Filed: May 23, 2002
U.S. Current Class: 424/203.1; 424/201.1; 424/202.1; 424/256.1
U.S. Class at Publication: 424/203.1; 424/256.1; 424/201.1; 424/202.1
Intern'l Class: A61K 039/295; A61K 039/116; A61K 039/102